Medi Caps' Q1 FY 2026-27 Quarterly Results

Result Summary

• Medi Caps Ltd reported a 68.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a decline of 6.0%.
• Its expenses for the quarter were down by 15.6% QoQ and 22.1% YoY.
• The net profit decreased 173.4% QoQ and decreased 36.1% YoY.
• The earnings per share (EPS) of Medi Caps Ltd declined at 1.79 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Medi Caps Ltd is a company whose primary operations are within the pharmaceutical industry, focusing on the production and distribution of gelatin capsules. The company serves both domestic and international markets, providing crucial inputs for pharmaceutical firms in developing medications. Despite being trained on data up to October 2023, there is limited information available about any recent major developments, expansions, or strategic shifts within the company. As such, the analysis will focus primarily on the financial data provided.

Revenue

For Q1FY27, Medi Caps Ltd reported a total income of ₹2.84 crores, a significant decline of 68.6% from the previous quarter (Q4FY26), where the total income was ₹9.04 crores. When compared year-over-year (YoY), there is a 6.0% decrease from the Q1FY26 income of ₹3.02 crores. This fall in revenue highlights a substantial contraction in income both on a quarterly and annual basis, indicating challenges in maintaining its revenue streams during the current period under review.

Profitability

The profitability metrics for Medi Caps Ltd in Q1FY27 reflect a challenging financial period. The company recorded a loss before tax of ₹-2.23 crores, which is a significant reversal from the profit of ₹3.03 crores reported in Q4FY26. This represents a QoQ decline of 173.6%. Compared to the previous year, the loss before tax improved by 36.1%, from ₹-3.49 crores in Q1FY26. After accounting for taxes—which remained at ₹0.00 crores in Q1FY27—the profit after tax mirrored the profit before tax, resulting in a net loss of ₹-2.23 crores. This trend is also reflected in earnings per share (EPS), which dropped to ₹-1.79 in Q1FY27 from ₹2.44 in Q4FY26, marking a QoQ decrease of 173.4% and a YoY improvement of 36.1% from ₹-2.80 in Q1FY26.

Operating Metrics

In Q1FY27, Medi Caps Ltd incurred total expenses of ₹5.07 crores, a reduction of 15.6% from the previous quarter's expenses of ₹6.01 crores. Year-on-year, expenses decreased by 22.1% from ₹6.51 crores in Q1FY26. This reduction in expenses, however, did not translate into improved profitability, as the company still faced a considerable loss. The absence of taxes in Q1FY27, consistent with the previous year's first quarter, indicates no taxable profit being achieved during these periods. The financial data suggests a focus on controlling costs, although revenue challenges have impacted the overall financial health of the company in Q1FY27.